BRIEF CHEMOIMMUNOTHERAPY WITH RITUXIMAB (R)-FND /- R MAINTENANCE AS FIRST LINE TREATMENT IN ADVANCED FOLLICULAR LYMPHOMA (FL) IN ELDERLY: PRELIMINARY ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL